Evidence map›Paper›PMID 27601478›Full record

ArticleCirculation research2016

Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer's Disease.

Susan A Austin, Zvonimir S Katusic

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  5. Cerebrovascular Endothelial Dysfunction: Role of BACE1.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  6. Article
  7. Pathogenic soluble tau peptide disrupts endothelial calcium signaling and vasodilation in the brain microvasculature.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Hypertension and cognitive dysfunction: a narrative review.Journal of Yeungnam medical science · 2023
    Article
  14. CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Inactivation of BACE1 increases expression of endothelial nitric oxide synthase in cerebrovascular endothelium.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Susan A AustinFrom the Departments of Anesthesiology and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN.
Zvonimir S KatusicFrom the Departments of Anesthesiology and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN. Katusic.zvonimir@mayo.edu.
Mayo Clinic · US

Funding

Endothelial Dysfunction In The Cerebral CirculationR01HL111062 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 2012 to 2016
$2.3M
Endothelial function of amyloid precursor proteinR01HL131515 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 2016 to 2019
$2.1M
NHLBI NIH HHS R01 HL111062NHLBI NIH HHS R01 HL131515
6 · The paper itself

Abstract

rationaleAlzheimer's disease has an unknown pathogenesis; however, cardiovascular risk factors are associated with a higher incidence of Alzheimer's disease. A defining feature of endothelial dysfunction induced by cardiovascular risk factors is reduced bioavailable endothelial nitric oxide (NO). We previously demonstrated that endothelial NO acts as an important signaling molecule in neuronal tissue.

objectiveWe sought to determine the relationship between the loss of endothelial NO synthase (eNOS) and tau phosphorylation in neuronal tissue. METHODS AND

resultsWe used eNOS knockout (

conclusionsOur data suggests that loss of endothelial NO plays an important role in the generation of p25 and resulting tau phosphorylation in neuronal tissue. These findings provide important new insights into the molecular mechanisms linking endothelial dysfunction with the pathogenesis of Alzheimer's disease.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsAntioxidantsBrain ChemistryCyclin-Dependent Kinase 5Disease Models, AnimalFemaleMaleMice, Inbred C57BLMice, KnockoutMicrogliaNeuronsNitric Oxide Synthase Type IIIPhosphorylationPhosphotransferasesAmyloid beta-Protein PrecursorAntioxidantsCdk5 protein, mouseCdk5r1 protein, mouseCyclin-Dependent Kinase 5Mapt protein, mouseNitric Oxide Synthase Type IIINos3 protein, mousePhosphotransferasesPresenilin-1Prostaglandin-Endoperoxide SynthasesProstaglandins Itau ProteinsAlzheimer’s diseaseCdk5cerebrovascular diseaseendothelial nitric oxide synthasetau

Identifiers

PMID27601478
PMCPMC5085902
OpenAlexW2515247062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.